References
- Waldum HL, Sordal O, Fossmark R. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences. Scand J Gastroenterol. 2018;53:639–642.
- Gueta I, Halkin H, Markovits N, et al. Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12. Gut. 2018;67:1904.
- Suissa S, Suissa A. Proton-pump inhibitors and increased gastric cancer risk: time-related biases. Gut. 2018;67:2228–2229.
- Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int. 2008;105:680–685.
- Bordi C, D’Adda T, Azzoni C, et al. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol. 1995;19:S8–S19.
- Fossmark R, Qvigstad G, Waldum HL. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol. 2008;14:1646–1651.
- Lai SW, Lai HC, Lin CL, et al. Proton pump inhibitors and risk of gastric cancer in a case-control study. Gut. 2018; pii: gutjnl-2018–316371.
- Niikura R, Hayakawa Y, Hirata Y, et al. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis. Gut. 2018;67:1908.